Literature DB >> 11165023

Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5.

A Krazeisen1, R Breitling, G Möller, J Adamski.   

Abstract

The 17beta-hydroxysteroid dehydrogenase type 5 (17beta-HSD 5) is involved in estrogen and androgen metabolism. In our study we tested the influence of environmental hormones, such as phytoestrogens (flavonoids, coumarins, coumestans), on reductive and oxidative 17beta-HSD activity of the human 17beta-hydroxysteroid dehydrogenase type 5 (17beta-HSD 5). These dietary substances were shown to be potent inhibitors of aromatase, different 17beta-HSDs and seem to play an important role in delay of development of hormone dependent cancers. Our studies show that reductive and oxidative activity of the enzyme are inhibited by many dietary compounds, especially zearalenone, coumestrol, quercetin and biochanin A. Among the group of flavones inhibitor potency is growing with increasing number of hydroxylations. We suggest that these substances are bound to the hydrophilic cofactor-binding pocket of the enzyme. An interesting inhibition pattern is observed for 18beta-glycyrrhetinic acid, which has no influence on the oxidative but only on the reductive reaction. This indicates that this substrate binds to pH- and cofactor-depending sites at the active center of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165023     DOI: 10.1016/s0303-7207(00)00422-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  17 in total

1.  Effect on abortion of feeding Korean pine needles to pregnant Korean native cows.

Authors:  Ill-Hwa Kim; Kyung-Chul Choi; Beum-Soo An; In-Gyu Choi; Byung-Ki Kim; Young-Kyoon Oh; Eui-Bae Jeung
Journal:  Can J Vet Res       Date:  2003-07       Impact factor: 1.310

2.  Dietary phytoestrogen intake is associated with reduced colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan Okey; Patricia Harper
Journal:  J Nutr       Date:  2006-12       Impact factor: 4.798

Review 3.  Role of phytoestrogens in cancer therapy.

Authors:  Mandeep K Virk-Baker; Tim R Nagy; Stephen Barnes
Journal:  Planta Med       Date:  2010-07-01       Impact factor: 3.352

Review 4.  Modulation of estrogen synthesis and metabolism by phytoestrogens in vitro and the implications for women's health.

Authors:  Majorie B M van Duursen
Journal:  Toxicol Res (Camb)       Date:  2017-09-08       Impact factor: 3.524

5.  The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells.

Authors:  Günter Vollmer; Janina Helle; Hakima Amri; Xunxian Liu; Julia T Arnold
Journal:  J Steroid Biochem Mol Biol       Date:  2011-12-22       Impact factor: 4.292

Review 6.  Virtual screening applications in short-chain dehydrogenase/reductase research.

Authors:  Katharina R Beck; Teresa Kaserer; Daniela Schuster; Alex Odermatt
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-09       Impact factor: 4.292

7.  Quercetin Induces Dose-Dependent Differential Morphological and Proliferative Changes in Rat Uteri in the Presence and in the Absence of Estrogen.

Authors:  Huma Shahzad; Nelli Giribabu; Muniandy Sekaran; Naguib Salleh
Journal:  J Med Food       Date:  2015-07-02       Impact factor: 2.786

8.  Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines.

Authors:  Nora E Gray; Xunxian Liu; Renee Choi; Marc R Blackman; Julia T Arnold
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-13

Review 9.  Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications.

Authors:  Elahe A Mostaghel; Peter S Nelson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-04       Impact factor: 4.690

10.  Daidzein administration positively affects thyroid C cells and bone structure in orchidectomized middle-aged rats.

Authors:  B Filipović; B Sosić-Jurjević; V Ajdzanović; D Brkić; M Manojlović-Stojanoski; V Milosević; M Sekulić
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.